<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The researchers conducted this study to test the hypothesis that risk of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is less following reductions in body size and central <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The <z:mp ids='MP_0002055'>Diabetes</z:mp> Prevention Program (DPP) recruited and randomized individuals with <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> to treatment with placebo, <z:chebi fb="0" ids="6801">metformin</z:chebi>, or lifestyle modification </plain></SENT>
<SENT sid="2" pm="."><plain>Height, weight, waist circumference, and subcutaneous and visceral fat at L2-L3 and L4-L5 by computed tomography were measured at baseline and at 1 year </plain></SENT>
<SENT sid="3" pm="."><plain>Cox proportional hazards models assessed by sex the effect of change in these variables over the 1st year of intervention upon development of <z:mp ids='MP_0002055'>diabetes</z:mp> over subsequent follow-up in a subset of 758 participants </plain></SENT>
<SENT sid="4" pm="."><plain>Lifestyle reduced visceral fat at L2-L3 (men -24.3%, women -18.2%) and at L4-L5 (men -22.4%, women -17.8%), subcutaneous fat at L2-L3 (men -15.7%, women -11.4%) and at L4-L5 (men -16.7%, women -11.9%), weight (men -8.2%, women -7.8%), BMI (men -8.2%, women -7.8%), and waist circumference (men -7.5%, women -6.1%) </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="0" ids="6801">Metformin</z:chebi> <z:mp ids='MP_0001262'>reduced weight</z:mp> (-2.9%) and BMI (-2.9%) in men and subcutaneous fat (-3.6% at L2-L3 and -4.7% at L4-L5), weight (-3.3%), BMI (-3.3%), and waist circumference (-2.8%) in women </plain></SENT>
<SENT sid="6" pm="."><plain>Decreased <z:mp ids='MP_0002055'>diabetes</z:mp> risk by lifestyle intervention was associated with reductions of body weight, BMI, and central body fat distribution after adjustment for age and self-reported ethnicity </plain></SENT>
<SENT sid="7" pm="."><plain>Reduced <z:mp ids='MP_0002055'>diabetes</z:mp> risk with lifestyle intervention may have been through effects upon both overall body fat and central body fat but with <z:chebi fb="0" ids="6801">metformin</z:chebi> appeared to be independent of body fat </plain></SENT>
</text></document>